The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study
Abstract
The course of systemic lupus erythematosus (SLE) is characterized by exacerbations (or flares) and remissions of disease activity. As part of an ongoing prospective cohort study, 3 disease activity indices, the physician's global assessment, the Lupus Activity Index, and the University of Toronto SLE Disease Activity Index, have been recorded, at least quarterly since 1987, on 185 SLE patients. We developed a definition of SLE flare and a description of its clinical epidemiology. Disease flare was defined as a change of ≥1.0 in the physician's global assessment of disease activity (measured on a 0–3 scale) from the previous visit or from a visit within the last 93 days. Of the 185 patients, 98 (53%) had ≥1 flare; the total number of flares was 146. The incidence of flare was 0.65 per patient‐year of followup. The median time from the first study visit to a flare was 12 months. Flares were frequently characterized by constitutional symptoms, musculoskeletal involvement, cutaneous involvement, and decreasing levels of C3 and C4. At the time of flare, the mean University of Toronto SLE Disease Activity Index score increased by 3.0 and the mean Lupus Activity Index score (modified to omit the physician's global assessment) increased by 0.26. Overall, 44.8% of the flares prompted a change in treatment. Patients who experienced flares fulfilled more of the SLE criteria at entry and had been followed up for a longer duration after entry into the study, compared with those who did not have flares. By survival analysis, no specific clinical or laboratory variables present at entry were found to predict the time to first flare. These data show that quantification of flare is possible, flare is frequent in patients with SLE of long duration, and the majority of flares involve the so‐called “minor” organ systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Self-citation(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Liang, M. H., Socher, S. A., Larson, M. G., & Schur, P. H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320909 · Cited by 789
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Outcome in Systemic Lupus Erythematosus: A Prospective Study of Patients from a Defined Population
JONSSON, H., NIVED, O., & STURFELT, G. (1989) · Medicine · doi:10.1097/00005792-198905000-00002 · Cited by 314
Fatal Infections in Systemic Lupus Erythematosus: The Role of Opportunistic Organisms
HELLMANN, D. B., PETRI, M., & WHITING-OʼKEEFE, Q. (1987) · Medicine · doi:10.1097/00005792-198709000-00002 · Cited by 228
Self-citation(1988) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068256 · Cited by 218
Measurement of systemic lupus erythematosus activity in clinical research
Liang, M. H., Socher, S. A., Roberts, W. N., & Esdaile, J. M. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310701 · Cited by 208
Swaak, A. J. G., Nossent, J. C., BRONSVELD, W., Rooyen, A. V., Nieuwenhuys, E. J., Theuns, L., & Smeenk, R. J. T. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.6.447 · Cited by 131
Cited by
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
Smyth, A., Oliveira, G. H. M., Lahr, B. D., Bailey, K. R., Norby, S. M., & Garovic, V. D. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240110 · Cited by 660
Hydroxychloroquine in lupus pregnancy
Clowse, M. E. B., Magder, L., Witter, F., & Petri, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22159 · Cited by 529
Self-citationStohl, W., Metyas, S., Tan, S., Cheema, G. S., Oamar, B., Xu, D., Roschke, V., Wu, Y., Baker, K. P., & Hilbert, D. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11354 · Cited by 503
Pons-Estel, B. A., Catoggio, L. J., Cardiel, M. H., Soriano, E. R., Gentiletti, S., Villa, A. R., Abadi, I., Caeiro, F., Alvarellos, A., & Alarcón-Segovia, D. (2004) · Medicine · doi:10.1097/01.md.0000104742.42401.e2 · Cited by 447
Mills, J. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302608 · Cited by 407
Frequency of lupus flare in pregnancy: The hopkins lupus pregnancy center experience
Petri, M., Howard, D., & Repke, J. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341210 · Cited by 390
Self-citationMosca, M., Tani, C., Aringer, M., Bombardieri, S., Boumpas, D., Brey, R., Cervera, R., Doria, A., Jayne, D., Khamashta, M. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117200 · Cited by 377
Self-citationRUIZ-IRASTORZA, G., LIMA, F., ALVES, J., KHAMASHTA, M. A., SIMPSON, J., HUGHES, G. R. V., & BUCHANAN, N. M. M. (1996) · Rheumatology · doi:10.1093/rheumatology/35.2.133 · Cited by 357
A Trial of Contraceptive Methods in Women with Systemic Lupus Erythematosus
Sánchez-Guerrero, J., Uribe, A. G., Jiménez-Santana, L., Mestanza-Peralta, M., Lara-Reyes, P., Seuc, A. H., & Cravioto, M.-D.-C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050817 · Cited by 352
Griffiths, B., Mosca, M., & Gordon, C. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.03.010 · Cited by 328
The use of laboratory tests in the diagnosis of SLE
Egner, W. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.6.424 · Cited by 316
Seror, R., Bootsma, H., Saraux, A., Bowman, S. J., Theander, E., Brun, J. G., Baron, G., Le Guern, V., Devauchelle-Pensec, V., Ramos-Casals, M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206008 · Cited by 316
Merkel, P. A., Lo, G. H., Holbrook, J. T., Tibbs, A. K., Allen, N. B., Davis, J. C., Hoffman, G. S., McCune, W. J., Clair, E. W. S., Specks, U., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00010 · Cited by 312
Self-citationBaechler, E. C., Bauer, J. W., Slattery, C. A., Ortmann, W. A., Espe, K. J., Novitzke, J., Ytterberg, S. R., Gregersen, P. K., Behrens, T. W., & Reed, A. M. (2007) · Molecular Medicine · doi:10.2119/2006-00085.baechler · Cited by 311
Costedoat‐Chalumeau, N., Amoura, Z., Hulot, J., Hammoud, H. A., Aymard, G., Cacoub, P., Francès, C., Wechsler, B., Huong, D. L. T., Ghillani, P., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22156 · Cited by 309
Bauer, J. W., Petri, M., Batliwalla, F. M., Koeuth, T., Wilson, J., Slattery, C., Panoskaltsis‐Mortari, A., Gregersen, P. K., Behrens, T. W., & Baechler, E. C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24803 · Cited by 297
Self-citationClassification and definition of major flares in SLE clinical trials
Petri, M., Buyon, J., & Kim, M. (1999) · Lupus · doi:10.1191/096120399680411281 · Cited by 282
Self-citationMorbidity of systemic lupus erythematosus: Role of race and socioeconomic status
Petri, M., Perez-Gutthann, S., Longenecker, J. C., & Hochberg, M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90151-m · Cited by 278
Self-citationGuidelines for referral and management of systemic lupus erythematosus in adults
(1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9<1785::aid-anr1>3.0.co;2-# · Cited by 269
Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody tests
Kavanaugh, A. F., Solomon, D. H., & The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines (2002) · Arthritis Care & Research · doi:10.1002/art.10558 · Cited by 225
Bootsma, H., Spronk, P. E., Borg, E. J. T., Hummel, E. J., de Boer, G., Limburg, P. C., & Kallenberg, C. G. M. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.11.661 · Cited by 115
Ramos-Casals, M., Campoamor, M. T., Chamorro, A., Salvador, G., Segura, S., Botero, J. C., Yagüe, J., Cervera, R., Ingelmo, M., & Font, J. (2004) · Lupus · doi:10.1191/0961203304lu1080oa · Cited by 91
Ordi-Ros, J., Sáez-Comet, L., Pérez-Conesa, M., Vidal, X., Mitjavila, F., Castro Salomó, A., Cuquet Pedragosa, J., Ortiz-Santamaria, V., Mauri Plana, M., & Cortés-Hernández, J. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210882 · Cited by 89
A surge in anti-dsDNA titer predicts a severe lupus flare within six months
Pan, N., Amigues, I., Lyman, S., Duculan, R., Aziz, F., Crow, M., & Kirou, K. (2014) · Lupus · doi:10.1177/0961203313515763 · Cited by 59
Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay
Hernando, M., González, C., Sánchez, A., Guevara, P., Navajo, J. A., Papisch, W., & González-Buitrago, J. M. (2002) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2002.185 · Cited by 35
López-Hoyos, M., Cabeza, R., Martínez-Taboada, V. M., Crespo, J., SanSegundo, D., Blanco, R., López-Escribano, H., Peña, M., & Rodríguez-Valverde, V (2005) · Lupus · doi:10.1191/0961203305lu2130oa · Cited by 27
Metadata
- Authors
- Petri, M., Genovese, M., Engle, E., & Hochberg, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1991-08
- Volume
- 34
- Issue
- 8
- Pages
- 937-944
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2062320562
- Cited by
- 340
- References
- 12
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.